Related Experiment Video
Updated: Aug 9, 2026
08:48
Bio-energetics Investigation of Candida albicans Using Real-time Extracellular Flux Analysis
Published on: March 19, 2019
Systemic fungal infections: an overview
1Department of Internal Medicine, Washington University School of Medicine, St. Louis.
Hospital Practice (Office Ed.)
|February 15, 1991
Abstract:
Increasingly more common, these infections pose diagnostic and therapeutic problems. The distinction between primary infection in healthy hosts and opportunistic infection in the immunocompromised remains clinically useful. Three major diseases in each category are discussed. A promising therapeutic advance is the introduction of orally administered azoles.
Insights
Common infections present diagnostic and therapeutic challenges. Oral azoles offer a promising new treatment approach for both primary and opportunistic infections in various patient groups.
Area of Science:
- Medical Mycology
- Infectious Diseases
- Pharmacology
Background:
- Fungal infections are increasingly prevalent, causing significant diagnostic and therapeutic difficulties.
- Distinguishing between primary infections in healthy individuals and opportunistic infections in immunocompromised patients is crucial for clinical management.
- This review focuses on three major fungal diseases in each category.
Purpose of the Study:
- To review the diagnostic and therapeutic challenges posed by common fungal infections.
- To discuss key fungal diseases affecting both healthy and immunocompromised hosts.
- To highlight recent advances in antifungal therapy.
Main Methods:
- Literature review of common fungal infections.
- Discussion of clinical presentations and management strategies.
- Evaluation of therapeutic options, including novel agents.
Main Results:
- Fungal infections require careful diagnosis due to varied presentations.
- Immunocompromised status significantly impacts infection risk and severity.
- Orally administered azoles represent a significant therapeutic advancement.
Conclusions:
- Effective management of fungal infections relies on accurate diagnosis and appropriate therapy.
- The development of oral azoles has improved treatment accessibility and efficacy.
- Continued research is needed to address emerging challenges in fungal disease treatment.
More Related Videos
Related Concept Videos
01:29Overview of Fungi
Fungi are a diverse group of eukaryotes more closely related to animals than other eukaryotes. Fungal cell walls comprise chitin, a polysaccharide that provides structural strength, and glucans, which contribute to flexibility and integrity. Other polysaccharides, such as mannans and galactosans, may supplement or replace chitin in some fungi. These adaptations, along with their preference for acidic environments and tolerance for high osmotic pressure, enable fungi to thrive in various...
01:29Fungal Group Zygomycota
Zygomycota, previously classified as a distinct fungal group, are primarily terrestrial, saprophytic molds that play a crucial role as decomposers. Recent phylogenetic studies have revealed that these fungi are now divided into two major clades — Mucoromycota, which includes many symbiotic species, and Zoopagomycota, which primarily consists of parasitic and pathogenic fungi. These groups exhibit distinct ecological roles and reproductive strategies while sharing key structural and...
01:28Fungal Phylum Microsporidia
Microsporidia are a group of obligate intracellular fungi that were initially classified as protists but were later reclassified based on phylogenetic, molecular, and structural evidence linking them to the Chytridiomycota. These unicellular, non-motile organisms are highly specialized parasites that infect a wide range of animal hosts, including humans. They have evolved extensive genomic and metabolic reductions, making them highly dependent on their hosts for survival.Morphology and Genomic...
01:28Fungal Phylum Ascomycota
Phylum Ascomycota, a major division within the subkingdom Dikarya, comprises a diverse range of fungal species, including both unicellular yeasts and filamentous molds such as Aspergillus and Penicillium. These fungi thrive in a variety of habitats, from aquatic ecosystems to terrestrial environments, playing crucial ecological and economic roles.Morphology and ReproductionThe defining characteristic of Ascomycetes, commonly referred to as sac fungi, is the ascus—a sac-like structure that...
01:27Cryptococcal Meningitis
Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
01:15Antifungal Agents
Amphotericin B is a broad-spectrum antifungal agent that exploits structural differences between fungal and mammalian cell membranes. Its amphipathic structure—featuring a hydrophobic polyene-lactone ring and a hydrophilic region containing mycosamine and carboxylic acid groups—enables selective binding to ergosterol, a sterol predominantly found in fungal plasma membranes. This selective interaction underlies the drug’s antifungal activity, although weak binding to cholesterol contributes to...